Objective: A significant reduction in the incidence of cardiovascular disease, including abdominal aortic aneurysm (AAA), has been observed in the past decades. In this study, a small but geographically well defined and carefully characterized population, previously screened for AAA and risk factors, was re-examined 11 years later. The aim was to study the reduction of AAA prevalence and associated factors.
In many countries, there has been a noticeable decrease in abdominal aortic aneurysm (AAA) prevalence and mortality, whereas in others, AAA mortality is stable or has even increased. 1 These different trends seem to correlate with variations of traditional cardiovascular risk factors. 1 The most important documented risk factors for AAA are high age, male sex, having a firstdegree relative with AAA, and smoking. Hypertension, hyperlipidemia, and abdominal obesity have also been associated with AAA. [2] [3] [4] [5] [6] Mortality from cardiovascular diseases was higher in the county of Västerbotten in northern Sweden than in the rest of Sweden in the 1970s and in the early 1980s. 7 The highest mortality in the county of Västerbotten was found in Norsjö municipality. The highest prevalence of AAA in a general population ever reported was found in a population-based screening study carried out in Norsjö municipality 1999. 8 Risk factors for cardiovascular diseases were recorded in the screened subjects.
To reduce mortality and morbidity in cardiovascular disease, health care providers and politicians started the Västerbotten Intervention Project (VIP) in 1985 with a pilot project in Norsjö (Fig 1) . The aim was to reduce cardiovascular morbidity and mortality by reduction of smoking, hypertension, and hypercholesterolemia, mainly by lifestyle changes (healthy food and physical activity). The strategy used was a combination of a population-based and an individual high risk-based program. 9 All men and women aged 40, 50, and 60 years were invited to an individual health screening including a questionnaire on significant cardiovascular risk factors. Body mass index (BMI) and blood pressure were measured, blood lipids were analyzed, and an oral glucose tolerance test was performed. A specialist nurse and, for high-risk patients, a physician offered personal feedback to every participant of the health survey. In 1991, this program was introduced in all municipalities in the county of Västerbotten. The population strategy included media information, public meetings, school programs, study groups, health information at work sites, dental care programs, courses on healthy food, physical activities, and labeling of healthy food (in general, food without high fat content) by a logo illustrating a keyhole on a green background. The effect on cardiovascular risk factors and the subsequent decline in cardiovascular morbidity and mortality have been previously published. [10] [11] [12] [13] Several studies have reported a marked reduction in AAA prevalence during the last years, mainly attributed to a significantly decreased smoking frequency. [14] [15] [16] [17] No results of the long-term effects of a broad cardiovascular intervention program on the prevalence of AAA have earlier been published. [14] [15] [16] [17] [18] [19] [20] The aim of this study was to investigate possible changes in the prevalence of AAA in Norsjö municipality and to relate this to changes in cardiovascular risk factors 11 years after the index survey (Fig 1) .
METHODS
The population. In 1999, Norsjö municipality had 4806 inhabitants. The first study, performed by Wanhainen et al in 1999, invited all men and women aged 65 to 75 years in the municipality of Norsjö to an AAA ultrasound screening. 8 For the second study, performed in 2010, all 602 men and women 65 to 75 years of age in Norsjö were invited to an AAA screening. The study was performed at the local health care center in Norsjö. In June 2011, all study participants were invited to donate blood for analyses of high-sensitivity C-reactive protein level, blood lipid profile, and creatinine concentration.
Ultrasound. The ultrasound examination in 1999 was performed by one experienced radiologist. The measurement differed from the current one in that the outer-toouter diameter was used. All study persons with an aortic diameter $28 mm were examined with computed tomography (CT). The diameter measured by ultrasound was used in all statistical calculations.
The AAA screening in 2010 was performed by two experienced sonographers with portable ultrasound equipment (Logiq e; GE Healthcare, Wauwatosa, Wisc) equipped with a 4 MHz transducer. The study was performed during three separate weeks, and each patient was examined once by one sonographer. The screening procedure was standardized. The infrarenal abdominal aorta was visualized longitudinally, and the largest anteroposterior (AP) diameter was measured by means of leading edge to leading edge, which means measuring the distance between the outermost part of the ventral wall of the aorta and the innermost part of the dorsal aortic wall. In all study persons with an AP aortic diameter $25 mm, measurement of the transverse aortic diameter was performed. An infrarenal aorta with an AP or transverse diameter $30 mm was defined as an AAA. All examinations were stored digitally. In a few cases in which the aortic diameter could not be measured reliably, the aorta was examined by a CT scan. Study participants with an aortic diameter of $30 mm were individually re-examined and informed at the Vascular Policlinic at Umeå University Hospital.
Risk factor collection. Height and weight were measured and BMI was calculated. Sitting systolic and diastolic blood pressure was measured in both arms with a mercury sphygmomanometer. All individuals with elevated blood pressure were advised to contact their general practitioner for additional measurements and potential treatment.
The same health questionnaire was used in the two surveys. Smoking was registered as current smoking, former smoking, and nonsmoking. Family history of AAA in first-degree relatives was registered. Selfreported occurrence of coronary heart disease, transient ischemic attack/stroke, peripheral arterial occlusive disease, and earlier cardiovascular surgery was recorded. Further, the presence of self-reported hypertension, chronic obstructive pulmonary disease, diabetes mellitus, renal failure, and cancer was registered. The current medication for each examined individual was obtained.
Blood samples were analyzed for plasma cholesterol, plasma high-density lipoprotein, plasma triglyceride, and creatinine concentrations. Plasma low-density lipoprotein concentration was calculated from the Friedewald formula. All analyses were done at the research unit at Skellefteå County Hospital during 1999 and 2011, respectively. Laboratory methods for analysis of blood lipids, creatinine, and high-sensitivity C-reactive protein were unchanged between 1999 and 2011.
The Research Ethics Review Board of northern Sweden approved the study (Dnr 09-185M and Dnr 2011-170-32M), and all participants gave written informed consent.
Statistics. The c 2 test or Fisher exact test was used to compare categorical variables. The Shapiro-Wilk normality test was used to test for normality. Normally distributed data were compared with independent samples t-test, and nonparametric data were compared with Wilcoxon rank sum test. A P < .05 was considered significant. R was used for statistical analyses. 21 
RESULTS
In the 1999 study, 504 (248 men and 256 women) of 555 inhabitants (91%) aged 65 to 75 years participated in the study. All 504 participants donated blood for further studies. Ultrasound screening detected aneurysms in 35 men, and by adding seven men who had undergone aortic aneurysm surgery, 16.9% of the examined men were diagnosed with an aneurysm. In 10 of the 35 men, CT examination did not confirm the diameter of $30 mm. Ultrasound screening detected eight aneurysms in women, and by adding one woman previously operated on, a prevalence of 3.5% was found. Two of the ultrasound-detected AAAs were not confirmed by CT.
In 2010, all 602 men and women aged 65 to 75 years were invited to participate, and 540 of 602 (90%) accepted (265 men and 275 women). Blood was donated by 456 persons.
All study participants were northern Europeans (except one born in Canada).
In the present study, the aortic diameter could be reliably measured by ultrasound in 535 of 540 (99%) individuals, and in 5 individuals, a CT scan was performed that resulted in discovery of an AAA in 1 woman. In three cases, the AP diameter was <30 mm but the transverse diameter was $30 mm, and these were included as aortic aneurysms. Including all aneurysms detected by ultrasound and CT and previously operated on AAAs, a total prevalence of 3.3% (18/540) AAA was found. The prevalence was 5.7% (15/265) among men and 1.1% (3/275) among women. An AAA was detected in 12 men and 3 women at the screening (diameter range, 30-58 mm). Two men with a previously operated on AAA attending the ultrasound screening and one man with a normal aortic diameter but with a common iliac artery aneurysm of 64 mm were included.
Comparing the present study in 2010 with the previous study in 1999. The prevalence of AAA decreased from 16.9% to 5.7% (P < .001) in men and from 3.5% to 1.1% (P ¼ .080) in women between 1999 and 2010 ( Table I) . The mean and median aortic diameter in both men and women was significantly lower in 2010 compared with 1999 (P < .001; Table I ).
Distribution of the aortic diameter determined by ultrasound in 1999 and 2010 is presented in Figs 2 and 3 , respectively.
Risk factors for cardiovascular disease and results of laboratory analyses (including missing data) in the 1999 and 2010 populations are presented in Table II for men and Table III for women. BMI was slightly lower in 2010 compared with 1999. Current smoking was unchanged, but a higher proportion of women were former smokers in 2010. The prevalence of diabetes mellitus did not differ significantly between the two surveys. Self-reported hypertension was more common in 2010, and medical treatment was given to 59% of all men and 66% of all women. The prevalence of transient ischemic attack/stroke among women was higher in 2010 than in 1999. On the other hand, ischemic heart disease was less frequent among men in the later survey compared with 1999. A significantly more favorable blood lipid profile was seen regarding cholesterol, high-density lipoprotein, and low-density lipoprotein concentrations among women but only for highdensity lipoprotein in men. Serum creatinine values increased in both sexes. As only 76% of the study participants from 2010 donated blood, a univariate statistical analysis was performed comparing the group donating blood with the group that did not regarding age, sex, aortic diameter, BMI, blood pressure, smoking habits, use of statins, and cardiovascular risk factors. There were no significant differences between the groups.
DISCUSSION
There was a highly significant reduction in the prevalence of AAA between 1999 and 2010 for men in Norsjö. The magnitude of this reduction for women was comparable to that for men but did not reach statistical significance, probably because of the low prevalence and small sample size. Several studies have reported a decreased prevalence of AAA, but this magnitude of reduction has never been presented previously. [14] [15] [16] [17] [18] [19] [20] Still, the AAA prevalence in Norsjö is three to four times higher compared with the reported current prevalence in Sweden for both men and women. 14, 20, 22, 23 Factors initiating aneurysm formation are unknown and factors affecting different growth rate in different individuals are poorly understood. Also, the lag time between aneurysm initiation and disease progression is unknown. So far, no study on medical treatment to reduce AAA growth has been successful. 24 However, modifiable factors such as smoking, hypertension, hypercholesterolemia, and abdominal obesity are associated with AAA. In our study, smoking was not less common in the 2010 population compared with the 1999 population, and in both studies, the smoking frequency was relatively low. A comparison of pack-years cannot be made because of lack of reliable data. The importance of smoking for development of AAA is well documented, and in our study, 87.5% of participants with an AAA were exposed to smoking.
2,4,5,14,25-27 Nevertheless, reduction of smoking cannot explain the reduced prevalence of AAA in the present study. Several studies have shown an association between hypertension and the prevalence of AAA. 2, 5, 14, 25, 26, 28 In the studied population, the awareness of hypertension as a cardiovascular risk factor has resulted in a high frequency of diagnosis and antihypertensive treatment. The effect of statin treatment on aneurysm formation and growth is unclear, with conflicting results in the literature. Several clinical observational studies reported an association between statin use and reduced AAA progression, [29] [30] [31] [32] [33] [34] whereas others failed to show an effect. [35] [36] [37] So far, no randomized controlled trial has investigated the effect of statin on AAA. In 1999, medical treatment for hypercholesterolemia was uncommon (only 2.8% in the population), but 34% of the study participants were treated with statins in 2010. In the present study, mean values of blood lipids for men were unchanged compared with 1999; but among women, a significant change toward a more favorable blood lipid profile was demonstrated. The importance of these small changes is unclear. A significant BMI reduction for both men and women between 1999 and 2010 was also found. Genetic factors also exist, but we found a relatively low proportion of family history of AAA compared with a mean frequency of 13% as reported by Björck and Wanhainen. 38 However, missing data for first-degree relatives are high in the two studies, and self-reported family history is uncertain. Hence, the observed marked reduction in AAA prevalence seen in Norsjö is not fully explained by the usual suspect, that is, changing smoking habits. More likely, improvement of other modifiable cardiovascular risk factors, such as better blood pressure control, statin treatment with better lipid levels, and possibly weight loss, may have an important role. Our data cannot explain the degree and extent of how the changes of the different risk factors examined in our study contribute to the reduction of AAA prevalence.
From the World Health Organization Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) study performed in the counties of Västerbotten and Norrbotten (including the municipality of Norsjö), we know that the traditional risk factors for cardiovascular disease and also cardiovascular mortality have decreased in this area. Between 1986 and 2009, in the 25-to 64-year-old population, mean blood pressure decreased 5.1/2.9 mm Hg in women and 1.7/0.3 mm Hg in men. 10 During the same period, regular smoking decreased from 26.4% to 11.5% in women and from 22.8% to 10.1% in men. 10 Total plasma cholesterol concentration decreased by 0.89 mmol/L in women and by 0.87 mmol/L in men. 10 It seems possible that the decrease in the prevalence of AAA could be related to changes in risk factors during the 1980s and 1990s. If so, it would implicate that the time lag between risk factor changes and development of AAA is longer than what is seen for myocardial infarction or stroke. The VIP includes other activities in the community that may have positive effects on vascular diseases that are not mediated through the traditional risk factors. Community activities and individual counseling including other parts toward a healthy lifestyle, like physical activity and healthy food choices, have been extensive. An inverse association between consumption of fruit and the risk of AAA has been described. 39 During the first decades of the VIP, coronary heart disease and stroke were significantly reduced in Västerbotten, and simultaneously a highly significant reduction of AAA prevalence in Norsjö has now been demonstrated. A possible reason that can contribute to the lower prevalence detected in 2010 could be that patients with prior AAA repair or with already known AAA declined to participate in the screening. However, since about 15 years ago, all operations for AAA and most of the surveillance for known AAA in the county of Väster-botten are done at the Surgical Department, Umeå University Hospital. None of the individuals not participating in the study has been operated on for AAA or has been under surveillance for an AAA. An important methodologic limitation of the current report is the different methods used to place the calipers in measuring the AP abdominal aortic diameter with ultrasound. In the 1999 study by Wanhainen, the aortic diameter was measured using the outermost ultrasound reflection with the transducer parallel to the longitudinal axis of the vessel and the outermost CT brightness of the infrarenal aorta, 40 whereas in the present study, the maximal AP diameter was measured according to the leading edge to leading edge principle. This can partly explain the pronounced reduction in mean aortic diameter as well as some of the differences seen in AAA prevalence. However, the aortic wall measures about 2 mm, so most of the observed differences in prevalence must have other explanations. In the first study using strict criteria that both ultrasound and CT measurement must be 30 mm or more to diagnose an aneurysm, 25 persons were diagnosed during the screening, and by adding the 7 men previously operated on, the prevalence among men was 12.9% (32/248) . This is also a high prevalence. Another weakness of this study is the relatively limited size of the study population. Although we found a clearly significant decrease in the prevalence of AAA in men, the decrease of similar magnitude in women was not statistically significant. The accuracy of self-reported risk factors and cardiovascular disease is subject to bias. However, screening for risk factors has been ongoing in this population since 1985.
The strength of the study is the homogeneous population in Norsjö. Norsjö is located in a sparsely populated, isolated area. Study participants have all been investigated at the same place during a short time, and the attendance rate was exceptionally high.
CONCLUSIONS
A highly significant reduction of AAA prevalence, during as short a period as 11 years, was demonstrated among men aged 65 to 75 years in Norsjö. Treatment for hypertension and with statins was frequent in 2010, whereas the frequency of current smoking was unchanged, so reduction of smoking cannot explain the reduced AAA prevalence. This indicates that a broad populationbased intervention to improve cardiovascular health, including lifestyle changes and treatment of cardiovascular risk factors, may also reduce AAA prevalence. 
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